Synektik, a Warsaw-based healthcare technology company, has partnered with Czech Republic-based Carebot to develop an AI-driven platform aimed at improving the diagnosis of lung diseases, including lung cancer. The collaboration, announced at ECR 2025, combines the companies’ advanced artificial intelligence (AI) technologies to enable faster and more accurate diagnoses across Polish healthcare facilities.
Carebot’s AI-powered CXR (chest X-ray) system analyzes X-ray images to identify both urgent and long-term pathological conditions, automatically generating editable medical reports. This system is designed to enhance the accuracy and efficiency of diagnoses. Synektik will facilitate the integration of Carebot’s AI tools into hospital systems and clinical workflows, ensuring smooth implementation within existing healthcare infrastructures.
The collaboration aims not only to modernize Poland’s healthcare system but also to enhance access to cutting-edge diagnostic technology in both urban and rural hospitals. The companies are focused on creating a unified diagnostic platform that combines state-of-the-art image analysis with clinical practice, allowing for better detection and management of lung diseases.
In addition, Carebot is expanding the capabilities of its system, with plans to include tools for musculoskeletal X-ray analysis and mammography screening, further extending the platform’s utility.
This partnership marks a significant step toward bridging the gap between large urban centers and smaller rural healthcare facilities, providing wider access to advanced medical technologies across Poland.
Related Topics
